MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $967,340 | -19.4% | 96,734 | +0.2% | 0.00% | -33.3% |
| Q2 2023 | $1,200,291 | -10.5% | 96,564 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $1,341,612 | -2.1% | 95,761 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,370,340 | -43.6% | 95,761 | +0.6% | 0.00% | -50.0% |
| Q3 2022 | $2,429,000 | -0.5% | 95,161 | +10.7% | 0.01% | 0.0% |
| Q2 2022 | $2,441,000 | -17.6% | 85,938 | +2.3% | 0.01% | 0.0% |
| Q1 2022 | $2,963,000 | -15.2% | 83,995 | +0.8% | 0.01% | 0.0% |
| Q4 2021 | $3,493,000 | +40.9% | 83,358 | +65.0% | 0.01% | +20.0% |
| Q3 2021 | $2,479,000 | +71.6% | 50,518 | +45.9% | 0.01% | +66.7% |
| Q2 2021 | $1,445,000 | – | 34,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |